1. Home
  2. PTIX vs AQB Comparison

PTIX vs AQB Comparison

Compare PTIX & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • AQB
  • Stock Information
  • Founded
  • PTIX 1994
  • AQB 1991
  • Country
  • PTIX United States
  • AQB United States
  • Employees
  • PTIX N/A
  • AQB N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • AQB
  • Sector
  • PTIX Health Care
  • AQB
  • Exchange
  • PTIX Nasdaq
  • AQB Nasdaq
  • Market Cap
  • PTIX 3.3M
  • AQB 2.9M
  • IPO Year
  • PTIX 2016
  • AQB N/A
  • Fundamental
  • Price
  • PTIX $3.83
  • AQB $0.74
  • Analyst Decision
  • PTIX
  • AQB
  • Analyst Count
  • PTIX 0
  • AQB 0
  • Target Price
  • PTIX N/A
  • AQB N/A
  • AVG Volume (30 Days)
  • PTIX 210.6K
  • AQB 217.2K
  • Earning Date
  • PTIX 08-13-2025
  • AQB 08-05-2025
  • Dividend Yield
  • PTIX N/A
  • AQB N/A
  • EPS Growth
  • PTIX N/A
  • AQB N/A
  • EPS
  • PTIX N/A
  • AQB N/A
  • Revenue
  • PTIX N/A
  • AQB N/A
  • Revenue This Year
  • PTIX N/A
  • AQB N/A
  • Revenue Next Year
  • PTIX N/A
  • AQB N/A
  • P/E Ratio
  • PTIX N/A
  • AQB N/A
  • Revenue Growth
  • PTIX N/A
  • AQB N/A
  • 52 Week Low
  • PTIX $2.35
  • AQB $0.47
  • 52 Week High
  • PTIX $15.54
  • AQB $1.94
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 53.21
  • AQB 43.79
  • Support Level
  • PTIX $3.55
  • AQB $0.75
  • Resistance Level
  • PTIX $3.97
  • AQB $0.85
  • Average True Range (ATR)
  • PTIX 0.23
  • AQB 0.08
  • MACD
  • PTIX 0.04
  • AQB -0.01
  • Stochastic Oscillator
  • PTIX 81.83
  • AQB 14.46

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About AQB AquaBounty Technologies Inc.

AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.

Share on Social Networks: